What is Rapport Therapeutics, Inc.'s shares (diluted)?

Rapport Therapeutics, Inc. (RAPP) reported shares (diluted) of 47.2M in Q1 2026.

How has Rapport Therapeutics, Inc.'s shares (diluted) changed year-over-year?

Rapport Therapeutics, Inc.'s shares (diluted) increased by 33.9% year-over-year, from 35.3M to 47.2M.

What does shares (diluted) mean?

The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Rapport Therapeutics, Inc. RAPP Shares (Diluted)

Shares (Diluted) at other companies

Supernus PharmaceuticalsSUPN

57.6M+3.2%

Xenon PharmaceuticalsXENE

87.3M+11.0%

Praxis Precision Medicines, Inc.PRAX

28.9M+37.2%

BiohavenBHVN

147.6M+44.8%

Septerna, Inc.SEPN

44.8M+1.9%

PVL

Palvella TherapeuticsPVLA

13.1M+18.8%

Other financials

Income statement

See full

Revenue$20.0M—

Operating income-$24.2M+10.7%

Net income-$19.9M+17.5%

EPS (diluted)-$0.42+38.2%

Balance sheet

See full

Cash & equivalents$78.1M+35.5%

Total debt$10.8M+37.8%

Total equity$471.5M+65.0%

Total assets$497.6M+64.7%

Cash flow

See full

Operating cash flow-$13.1M+35.5%

CapEx$86.0K-70.4%

Free cash flow-$13.1M+36.0%

Valuation

See full

Market cap$1.86B+309%

Enterprise value$1.79B+352%

Returns & leverage

See full

Return on equity-28.3%—

Debt / equity0×0.0×

Current ratio27.1×-3.9×

Where this comes from

Reported directly by Rapport Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapport Therapeutics, Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rapport Therapeutics, Inc.'s shares (diluted)?: Rapport Therapeutics, Inc. (RAPP) reported shares (diluted) of 47.2M in Q1 2026.
How has Rapport Therapeutics, Inc.'s shares (diluted) changed year-over-year?: Rapport Therapeutics, Inc.'s shares (diluted) increased by 33.9% year-over-year, from 35.3M to 47.2M.
What does shares (diluted) mean?: The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.